Navigation Links
Golden Meditech Brings in Financial Investor Through New Share Issuance
Date:11/27/2008

HONG KONG, Nov. 27 /PRNewswire-Asia-FirstCall/ -- China's leading integrated medical device and healthcare services provider, Golden Meditech Company Limited ("Golden Meditech" or "the Company", Stock Code: 8180.HK) is pleased to announce today that the Company has successfully brought in Atlantis Investment Management Limited ("Atlantis Investment") as financial investors through an allocation of 60 million new ordinary shares at a price HK$1.03 per share.

Mr. KAM Yuen, Chairman and CEO of Golden Meditech, said that despite the global financial crisis has caused extreme volatility in the capital market that resulted in numerous companies' fundamentals being casually ignored, Golden Meditech has demonstrated its ability to bring in new financial investor. It represents a vote of confidence from the investment community and a conviction of Golden Meditech strong fundamentals and promising outlook which was temporarily overshadowed by the pessimism in the capital market.

"We are honored to see that Atlantis Investment shares the same vision as we do with China's burgeoning healthcare industry and such a strategic investor-ship will not only strengthen Golden Meditech shareholders base, but also be beneficial to our long-term growth," said Mr. KAM.

"To act in the best interest of our shareholders, Golden Meditech has always been striving to maximize shareholders value. While enhancing the shareholder value, we also engage in various defensive measures, including share repurchases, for the purpose of preserving shareholder value," said Mr. KAM.

The net proceeds raised will be used for general working capital, and to fund future investment opportunities.

As of September 20, 2008, Golden Meditech reported sustained high growth of key businesses and recorded revenues of HK$241 million in the first half of financial year 2008/09, representing a 27% growth on a year on year basis. Net profit attributable to shareholders of the same period was HK$147 million.

Golden Meditech: Founded in 2000 and listed on the Growth Enterprise Market of the Stock Exchange of Hong Kong Limited in December 2001, Golden Meditech is the first hi-tech medical device enterprise that went public outside of the PRC. During the past few years, thanks to its great efforts in innovation and market expansion, as well as its first-mover abilities in capturing the emerging market opportunities, Golden Meditech's medical devices, cord blood banking services and natural herbal medicines have all established dominant positions in their own sectors. Going forward, Golden Meditech will continue its pursuit of becoming China's leading integrated medical group through organic growth, acquisitions and strategic investments.

Atlantis Investment Management Limited: an independent Asian equity asset management firm with over US$4.5bn under management as at January 31, 2008, with a focus on China and the Asia-Pacific countries.

    For inquiries, please kindly contact:

     Investor Relations Division
     Golden Meditech Company Limited
     Address: 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong.
     Tel:     +852-3605-8138
     Fax:     +852-3605-8181
     Email:   ir@goldenmeditech.com

'/>"/>
SOURCE Golden Meditech Company Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Golden Meditech Releases FY2008/09 Interim Results
2. Golden Meditech Increases Stakes in Cordlife, Largest Cord Blood Bank Operator in Southeast Asia
3. U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes
4. Dataline Announces Participation in Operation Golden Phoenix
5. Golden Meditech Pioneers into Chinas Hospital Market
6. Golden Gate University Opens New Student Services Center
7. Golden Meditech Donates HKD 4 Million to Earthquake Victims
8. Golden Rainbow Takes a Musical Journey for Its 22nd Annual Ribbon of Life Production Show
9. Golden State Medical Supply Selects IBM Technology to Comply With California Prescription Drug Pedigree Regulations
10. American Airlines Honors Flight Attendants at Golden Heart Awards Ceremony
11. Author Elizabeth Golden and Dancer Sarah Patellos to Serve as National Spokespersons for the National Scoliosis Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... ... anticipated, web-based software module. The cutting-edge feature provides end users with an ... Izenda’s self-service business intelligence solution and its analytics engine. , This ...
(Date:5/24/2016)... ... May 24, 2016 , ... Celebration is in the Air, ... its 5th Annual Photo Contest. The label contest is underway, and hundreds of ... include a GoPro Hero4, a 40-inch high-definition flat-screen television, an Apple iPad Air ...
(Date:5/23/2016)... ... 23, 2016 , ... On Sunday, May 15, Rockynol Retirement ... assisted living center. After 18 months of construction, the new state-of-the-art structure was ... provides the latest in assisted living amenities and services, offering six different studio ...
(Date:5/23/2016)... ... ... Edward D. Buckingham, M.D . is excited announce that he has been ... out by the National Consumer Advisory Board to honor excellence in medicine. Only doctors ... award. , The National Consumer Advisory Board (NCAB) is a private organization created to ...
(Date:5/23/2016)... Angeles, CA (PRWEB) , ... May 23, 2016 , ... ... surgeons have noted that, less than 1% of United Kingdom residents who could benefit ... UK’s National Health Service (NHS) increases the number of bariatric procedures it offers to ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 2016 Een app die artsen ... collectief patiënten kunnen behandelen, hun kennis kunnen delen en ... de nieuwe en revolutionaire MDLinking App, ontwikkeld door een ... dr. Hans Flu en oncologisch chirurg dr. Gijs ... is, wordt op dinsdag 24 mei officieel gepresenteerd op ...
(Date:5/23/2016)... 2016 Transparency Market Research has ... Insufficiency Market - Global Industry Analysis, Size, Share, Growth, ... the report, the exocrine pancreatic insufficiency market is anticipated ... to 2023 to reach US$2.85 Bn by 2023. ... by the deficiency of the exocrine pancreatic enzymes, causing ...
(Date:5/23/2016)... May 23, 2016 Non-invasive diagnostic ... of multiple diseases; ,Technology to be presented at Yissum’s ... Yissum Research Development Company of the Hebrew University of ... research agreement with Aurum Ventures MKI, the technology investment arm ... a new diagnostic approach for early detection of multiple ...
Breaking Medicine Technology: